The Role of Tissue-Resident Donor T Cells in Rejection of Clinical Face Transplants
Abstract
Unlike solid organ transplants, face transplants have a unique immunological characteristic the presence of skin, which contains approximately 1 million T cell/cm2. A full face transplant is 600-700 cm2 in size and therefore, contains approximately 600-700 million donor T cells. The long-term persistence of donor T cells within facial allografts and the role of donor vs. recipient T cells in face transplant rejection are two critical issues that have never been studied. We plan to (i) quantify the number and diversity of donor vs. recipient T cells within face transplants over time using cutting edge high throughput TCR sequencing (HTS), (ii) identify pathogenic T cell clones implicated in rejection, (iii) identify if these pathogenic T cell clones are of donor vs. recipient, and (iv) determine if these pathogenic T cell clones are measurable in blood during episodes of rejection and could therefore serve as an earl and personalized biomarker of rejection.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2017
- Accession Number
- AD1046207
Entities
People
- Bohdan Pomahač
Organizations
- Brigham and Women's Hospital